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CD44-mediated neutrophil apoptosis in the rat. Neutrophils play a key role in host defense against
Background. Apoptosis is an important mechanism by microorganisms. Upon activation, neutrophils secrete a
which neutrophils are removed from sites of inflammation, wide range of molecules, such as reactive oxygen speciesincluding the kidney. This study investigated whether ligation
and proteolytic enzymes, which can kill invading micro-of the cell-surface adhesion molecule, CD44, can trigger neu-
trophil apoptosis. organisms but also cause substantial local tissue damage.
Methods. The anti-rat CD44 antibody OX-50 was used to Thus, tight control of neutrophil activation is important
induce apoptosis of cultured blood neutrophils, as determined in preventing excessive tissue damage. A number of stud-by flow cytometry using annexin V staining and by transmission
ies have provided histologic evidence that inflammatoryelectron microscopy. The functional consequences of OX-50–
mediated neutrophil depletion were examined in a rat model neutrophils undergo apoptosis followed by phagocytic
of accelerated antiglomerular basement membrane glomerulo- clearance by macrophages in different sites, including the
nephritis. joint, lung, and gut [1–4]. Similarly, neutrophil-dependentResults. Flow cytometric analysis using the OX-50 antibody,
injury in the very early stages of antiglomerular base-which recognizes the common amino terminal domain of CD44,
ment membrane (GBM) glomerulonephritis is resolvedshowed that rat blood neutrophils express very high levels of
CD44. The addition of OX-50, but not control antibodies, rap- by neutrophil apoptosis followed by phagocytosis by
idly induced neutrophil apoptosis in cultured rat blood leuko- mesangial cells and macrophages [5]. A number of mole-
cytes, as demonstrated by annexin V staining and by electron
cules that participate in human monocyte recognition ofmicroscopy. Cross-linking of CD44 was essential since F(ab)
apoptotic neutrophils, including the avb3 integrin, throm-fragments of the OX-50 antibody failed to induce neutrophil
apoptosis. The CD44 ligand hyaluronan and an antibody to bospondin 1, CD36, and CD44, have been identified [6–8].
the CD44v6 isoform failed to induce neutrophil apoptosis, indi- CD44 is a cell-surface glycoprotein constitutively ex-
cating that OX-50 antibody-mediated neutrophil apoptosis is
pressed by a wide range of cell types, including lympho-epitope specific. This effect was specific to neutrophils since
cytes, macrophages, fibroblasts, tubular epithelial cells,the OX-50 antibody did not induce apoptosis in other CD44-
expressing cell types (lymphocytes, mesangial cells, or tubular and proliferating mesangial cells [9, 10]. CD44 has a
epithelial cells). An injection of OX-50 antibody into normal large number of isoforms created by alternative RNA
rats caused a rapid and profound neutropenia, and apoptotic
splicing of at least 10 variant exons [9, 11]. Hyaluronanneutrophils could be seen in the blood by electron microscopy.
and osteopontin are the major CD44 ligands [12, 13],Furthermore, the administration of OX-50 antibody abrogated
neutrophil-dependent glomerular injury (proteinuria) on day 1 although other extracellular matrix proteins such as col-
of rat antiglomerular basement membrane glomerulonephritis, lagen and fibronectin can also bind to CD44 [11, 14, 15].
whereas injury on day 10 of the disease (neutrophil indepen-
A wide range of biological functions have been attrib-dent) was largely unaffected.
uted to CD44. The CD44–hyaluronan interaction facili-Conclusions. The cross-linking of specific epitopes of the
CD44 molecule can rapidly induce neutrophil apoptosis in vitro tates lymphocyte–endothelial cell adhesion in vitro un-
and inhibit neutrophil-dependent renal injury in vivo. This der flow conditions [16], and anti-CD44 antibodies can
finding suggests that physiological ligands of the CD44 mole-
induce T-lymphocyte activation [17]. Expression of thecule may play an important role in eliminating neutrophils from
alternatively spliced isoform, CD44v6, has been impli-sites of inflammation, including inflammatory kidney disease.
cated in tumor metastasis and lymphocyte activation [11,
18–21]. In addition, anti-CD44 antibodies have beenKey words: glomerulonephritis, monocyte, tubular epithelium, lym-
phocyte, infection, cell death, intracellular signaling. shown to activate cytokine production by monocytes [22].
Intracellular signaling can be triggered in neutrophils
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METHODS Culture of cell lines
The NRK52E rat tubular epithelial cell line was main-Antibodies and hyaluronan
tained in Dulbecco’s modified Eagle’s medium (DMEM)Monoclonal antibodies (mAbs) used in this study were
supplemented with 10% FCS and 1% nonessentialas follows: OX-50, anti-rat CD44 (IgG1) [24, 25]; A2.6,
amino acids. The 1097 rat mesangial cell line [10] wasanti-rat CD44v6 isoform (IgG1) [20, 26]; OX-1, anti-rat
maintained in RPMI 1640 supplemented with 5% FCS.CD45 (leukocyte common antigen; IgG1) [27]; ED1, anti-
Since CD44 is exquisitely trypsin sensitive, flow cytome-rat CD68 (macrophage specific antigen; IgG1) [28, 29];
tric analysis of CD44 expression was performed as fol-and W3/13, anti-rat CD43 (sialoglycoprotein expressed
lows. Cells were harvested by trypsinization, washed,by T cells and neutrophils; IgG1) [30]. Two negative con-
and then cultured overnight in Teflon bags. Cells weretrol mouse mAb were used, 73.5 (IgG1) and PHM1 (IgG1),
then harvested and analyzed as by flow cytometry as
which recognize human leukocytes but do not react with
described in the next section.
rat tissues. Peroxidase-conjugated goat anti-mouse IgG
and mouse peroxidase antiperoxidase complexes (PAP) Flow cytometry
were purchased from (Dako, Carpinteria, CA, USA). Analysis of cell-surface antigens was performed as fol-
F(ab) fragments of OX-50 IgG were prepared by pa- lows: Heparinized blood was mixed with an equal volume
pain digestion as follows: Purified IgG at 20 mg/mL in of Q-prep (Beckman-Coulter, Hialeah, FL, USA), which
phosphate-buffered saline (PBS), supplemented with 10 lyzes red blood cells and platelets and fixes leukocytes.
mmol/L l-cysteine and 2 mmol/L ethylenediaminetetra- The leukocytes were washed twice in PBS containing 1%
acetic acid (EDTA), was incubated with 20 mg/mL of FCS. Samples (5 3 105 cells) were incubated with 10 mg/mL
papain-agarose (Sigma Chemical Co., St. Louis, MO, of each mAb in the previously mentioned buffer for 30
USA) with gentle agitation at 378C for 18 hours. The minutes at 48C, washed twice, incubated with fluorescein
digested IgG was then applied to a Protein-G sepharose isothiocyanate (FITC)-conjugated sheep anti-mouse IgG
column (Pharmacia Biotech, Uppsala, Sweden). The un- for 30 minutes at 48C, washed once, and then analyzed
bound fraction containing F(ab) fragments was collected on a MoFlo flow cytometer (Cytomation, Fort Collins,
and dialyzed against PBS, and the protein content was CO, USA) equipped with Cyclops SUMMIT software.
quantitated by absorbance at 280 nm. Digestion was Cells were excited with a 488 nm argon ion laser, and
confirmed by sodium dodecyl sulfate-polyacrylamide gel up to four parameters were collected at one time. Neu-
electrophoresis (SDS-PAGE) analysis. The OX-50 F(ab) trophils and lymphocytes were gated on the basis of
forward versus 908 light scatter with at least 5000 gatedfragments maintained activity on the basis that they par-
cells evaluated. The neutrophil and lymphocyte gatestially inhibited OX-50 IgG binding to neutrophils, as
were confirmed by comparing the scatter profiles ofassessed by flow cytometry.
W3/13 mAb-stained cells (neutrophils and T lympho-Purified high molecular weight hyaluronan (Healon)
cytes) with that of W3/25-stained cells (CD41 T lympho-was a gift from Pharmacia. A low molecular weight hya-
cytes). The percentage of positive cells was determinedluronan fraction was prepared by incubating Healon 1
from a cutoff set using an isotype-matched, nonspecificmg/mL in 300 mmol/L sodium phosphate buffer, pH 5.35,
control antibody.with bovine testicular hyaluronidase (Sigma) at 5 U/mg
Analysis of cell apoptosis was based on binding ofHealon for 20 minutes prior to heat inactivation of the
annexin V to the cell surface [32]. Rat leukocytes, cul-enzyme. Production of 40 to 80 kD hyaluronan fragments
tured as described previously in this article, were washedwas confirmed by gel electrophoresis using the method
once in PBS and resuspended in 100 mL of annexin Vof Lee and Cowman [31].
binding buffer (Pharmingen, San Diego, CA, USA). Five
microliters of FITC-conjugated annexin V (Pharmingen)Culture of rat blood leukocytes
and 5 mg/mL propidium iodide (Sigma) were added.
Inbred male Sprague-Dawley rats were obtained from Cells were mixed gently and incubated for 15 minutes
Monash Animal Services (Melbourne, Australia). Hepa- at room temperature in the dark. Samples were then
rinized blood was collected by cardiac puncture of anes- diluted with 400 mL of binding buffer and analyzed by
thetized rats. Red blood cells were removed by ammo- two-color flow cytometry, as described previously in this
nium chloride lysis, and the cells were washed twice in article. Apoptotic cells were distinguished from normal
PBS with 1% fetal calf serum (FCS). Cells were resus- and necrotic cells by labeling with annexin V and exclu-
pended in RPMI 1640 medium with 5% FCS and were sion of propidium iodide.
cultured at 378C in a 5% CO2 incubator in the presence
Electron microscopyof 20 mg/mL of different mAb or 100 to 500 mg/mL
hyaluronan. Cells were then harvested and analyzed by Rat blood leukocytes were cultured with OX-50 or
the control 73.5 mAb for 0, 20, 60, or 120 minutes andflow cytometry or electron microscopy.
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were then fixed in 2.5% gluteraldehyde for one hour and drained, incubated with ED1 or W3/13 mAb, washed
washed in 5% sucrose in 0.1 mol/L PBS, pH 7.4. Cells (three times) in PBS, dehydrated through alcohol and
were pelleted, postfixed in 1% osmium tetroxide, dehy- endogenous peroxidase inactivated in 0.3% H2O2 in
drated in graded acetone, and embedded in Epon Araldite. methanol. Sections were then incubated with peroxidase-
Sections were stained with uranyl acetate and lead citrate conjugated goat anti-mouse IgG followed by mouse PAP
and examined with a Philips CM12 electron microscope. and were developed with 3,3-diaminobenzidine to give
a brown product. Sections were counterstained with he-
Experimental glomerulonephritis matoxylin and mounted. An isotype-matched mouse
Accelerated anti-GBM glomerulonephritis was induced mAb (73.5) was used as the negative control.
in inbred male Sprague-Dawley rats (150 to 200 g) as
Statisticspreviously described [33]. Briefly, animals were immu-
nized with 5 mg normal sheep IgG in Freund’s complete Statistical analysis was performed using GraphPad
adjuvant and injected intravenously with 10 mL/kg sheep Prism 3.0 (GraphPad Software, San Diego, CA, USA).
anti-rat GBM serum five days later (termed day 0). In
experiment 1, disease was induced in groups of four rats,
RESULTSwhich were treated by an intraperitoneal injection of 10
mg/kg OX-50 IgG or control PHM1 IgG three hours CD44 expression by blood neutrophils
before the administration of anti-GBM serum. These Flow cytometric analysis with the OX-50 mAb found
animals were killed on day 1. In experiment 2, disease that rat blood neutrophils express high levels of CD44,
was induced in groups of six rats, which received intra- comparable to the high level of expression of the leuko-
peritoneal injections (10 mg/kg) of OX-50 or control cyte common antigen (OX-1; Fig. 1). In contrast, CD44
PHM1 mAb every second day, starting three hours be- was weakly expressed by a subset of blood lymphocytes
fore the administration of anti-GBM serum, until being in a pattern similar to that previously reported for rat
killed on day 10. A 24-hour skin delayed-type hypersen- splenocytes [24]. The CD44v6 isoform, detected by the
sitivity (DTH) response was performed over days 9 and A2.6 mAb, is expressed at low levels on blood neutro-
10. Rats were shaven on the back and injected subcutane- phils, but is absent from blood lymphocytes (Fig. 1).
ously at different sites with 50 mL of sheep IgG (1 mg/
mL), rabbit IgG (1 mg/mL), or PBS. After 24 hours, skin Anti-CD44 mAb induces neutrophil apoptosis in vitro
swelling was measured with a micrometer. Neutrophils spontaneously undergo apoptosis when
cultured in vitro. Spontaneous neutrophil apoptosis wasRenal function and proteinuria
observed in cultured rat blood leukocytes (Fig. 2). How-Protein excretion in 24-hour urine collections was de-
ever, the addition of the OX-50 mAb caused a dramatictermined using the benzethonium chloride method. Con-
increase in neutrophil apoptosis. This was evident bycentrations of plasma and urine creatinine were mea-
the .50% reduction in the number of cells within thesured using the standard Jaffe rate reaction (alkaline
neutrophil gate in the forward versus 908 scattergrampicrate method). Whole blood cell counts were per-
(Fig. 2C) and the 2.5-fold increase in the percentage offormed on a Cell-Dyn 3500 automated cell counter (Ab-
apoptotic neutrophils defined as annexin V-positive andbott Laboratories, Abbott Park, IL, USA) using heparin-
propidium iodide-negative (AV1PI2) cells (Fig. 2D).ized blood collected from tail veins.
The reduction in the number of neutrophils in the for-
ward versus 908 scattergram was due to apoptotic neutro-Histopathology
phils becoming small and condensed, thus moving outTissues for histology were fixed in 4% formalin, and
of the normal neutrophil gate position. Increased neutro-4 mm paraffin sections were stained with periodic acid-
phil apoptosis was evident within 20 minutes of OX-50Schiff (PAS) reagent. The percentage of glomeruli exhib-
mAb addition and was maximal at one hour. This wasiting atrophy/segmental sclerosis or glomerular cres-
a specific effect since binding of the OX-1 mAb to thecentic formation was assessed by examination of at least
highly expressed leukocyte common antigen failed to100 glomerular cross-sections (gcs) per animal.
induce neutrophil apoptosis (Fig. 2E). In addition, the
Immunohistochemistry A2.6 and irrelevant control mAb had no effect on neutro-
phil apoptosis (Fig. 2E).Immunohistochemistry staining was performed as pre-
OX-50 mAb-induced neutrophil apoptosis was con-viously described [34]. Paraffin-embedded, formalin-fixed
firmed by electron microscopy, which showed the pres-kidney sections (4 mm) were dewaxed, placed in 0.01
ence of many apoptotic neutrophils, whereas lympho-mol/L sodium citrate buffer, pH 6.0, and heated for 10
cytes remained normal (Fig. 3). Neutrophils undergoingminutes in a microwave oven at 800 W to facilitate anti-
apoptosis were characterized by shrinkage and blebbinggen retrieval. After cooling, tissue sections were blocked
by incubation in 10% sheep serum and 10% FCS in PBS, of the cell accompanied by condensation of the cyto-
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Fig. 1. CD44 expression by rat blood leuko-
cytes. Cells were labeled with 73.5 (control),
OX-50, A2.6, or OX-1 antibodies, as indi-
cated, and were analyzed by flow cytometry.
Cells were gated for neutrophils (A–D) and
lymphocytes (E–H ). The percentage of posi-
tive cells (in parenthesis) was determined by
a cutoff (vertical line) based on the results of
the negative control antibody (73.5).
plasm and dilation of the endoplasmic reticulum. The and condensed rounded nuclear fragments. Apoptosis
was not observed within lymphocytes.nuclei showed profound chromatin condensation, ini-
tially around the nuclear periphery, and there was loss Cross-linking was required for OX-50–induced neu-
trophil apoptosis on the basis that F(ab) fragments ofof the nuclear membrane (Fig. 3). At later stages of
apoptosis, neutrophils were broken up into membrane- the OX-50 antibody failed to induce apoptosis (Fig. 4).
High concentrations of either high or low molecularbound spherical bodies containing compacted organelles
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Fig. 2. Anti-CD44 antibody induces neutro-
phil apoptosis in vitro. Rat blood leukocytes
were cultured for 60 minutes in RPMI with
5% FCS in the presence of different antibod-
ies. Cells were then incubated with annexin
V-FITC (AV, FL1) and propidium iodide (PI,
FL3) and were analyzed by two-color flow
cytometry. The neutrophil population was
gated on the basis of forward light scatter
(FSC) versus 908 side scatter (SSC). The fluo-
rescence profiles were determined for the
gated cells. (A and B) 73.5 control antibody.
(C and D) OX-50 antibody. Values in the
fluorescence scattergrams represent the per-
centage of cells within each quadrant. (E )
Quantitation of the percentage of apoptotic
neutrophils (AV1PI2 cells). Data are mean 6
SD from six experiments. **P , 0.01 vs. con-
trol by Dunnett’s multiple comparison test
(ANOVA).
weight hyaluronan, the major CD44 ligand, did not in- not shown). However, OX-50 IgG induced activation of
1097 mesangial cells on the basis of secretion of mono-duce neutrophil apoptosis (Fig. 4).
As a further test of the specificity of CD44-mediated cyte chemoattractant protein-1 (data not shown). The
addition of OX-50 IgG to rat NRK52E tubular epithelialneutrophil apoptosis, we studied the effects of adding
OX-50 mAb to cultured mesangial cells and tubular epi- cells had no effect on cell viability (data not shown).
thelial cells. Both of these cell lines express CD44 as
Anti-CD44 mAb induces neutrophil apoptosis in vivodemonstrated by flow cytometry (Fig. 5), consistent with
previous studies [10, 35]. The addition of OX-50 IgG Intravenous injection of 10 mg/kg of an irrelevant mAb
into normal rats had no effect on blood neutrophil andhad no effect on the viability or cell proliferation of the
rat 1097 mesangial cell line and was unable to inhibit lymphocyte profiles, as determined by flow cytometry
(Fig. 6A). In contrast, an injection of the OX-50 mAbmesangial cell adhesion to hyaluronan-coated wells (data
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Fig. 4. Effect of cross-linking on CD44-mediated neutrophil apoptosis
in vitro. Rat blood leukocytes were incubated for 60 minutes at 378C with
OX-50 IgG, OX-50 F(ab) fragments, high molecular weight hyaluronan
(HMW HA; 500 mg/mL), or low molecular weight hyaluronan (LMW
HA; 500 mg/mL), and apoptosis was analyzed by flow cytometry using
annexin V-FITC and propidium iodide. Data are mean 6 SD from
three experiments. **P , 0.01 vs. 73.5 control by Dunnett’s multiple
comparison test (ANOVA).
the administration of sheep anti-GBM serum [33]. This
model features a transient glomerular neutrophil influx
during the first six hours following the administration of
Fig. 3. Transmission electron microscopy of OX-50 antibody–induced anti-GBM serum, which disappears within 24 hours [33].
neutrophil apoptosis. Rat blood leukocytes were cultured for 60 minutes Glomerular injury (proteinuria) during the first 24 hourswith the OX-50 antibody and were then processed for electron micros-
is neutrophil dependent [36, 37], as is skin swelling duringcopy. Several neutrophils (N) are seen in the process of apoptosis.
There is condensation of the cytoplasm with dilation of the endoplasmic the first 24 hours of the DTH response [38, 39]. In con-
reticulum. The nuclei show profound peripheral chromatin condensa-
trast, the development of proteinuria later in this diseasetion and have broken up into rounded bodies. The neutrophil at the
top of the figure demonstrates early pinching off of a membrane-bound model is dependent on T cells and macrophages [40].
near spherical body (arrow). The lymphocyte (L) shows no evidence Control mAb-treated animals developed significant
of apoptosis (39450).
glomerular injury (proteinuria) within 24 hours of ad-
ministration of anti-GBM serum, which was associated
with glomerular infiltration of W3/131 cells and ED11
into normal rats caused a dramatic loss of cells from the monocytes (Fig. 8 A–C). No neutrophils were observed
neutrophil gate, while blood lymphocytes were unaffected in glomeruli at 24 hours on hematoxylin and eosin-
(Fig. 6B). Whole blood counts confirmed a massive neu- stained sections; therefore, glomerular W3/131 cells
tropenia (111 6 55 vs. 1650 6 320 neutrophils/mL in were deemed to be T cells. Treatment of animals with
OX-50 vs. 73.5 mAb treated animals, P , 0.001; normal
OX-50 mAb depleted circulating neutrophils, whereas
is 1630 6 200 neutrophils/mL). Blood neutrophil counts
only a minor effect on circulating lymphocyte numbersremained suppressed for 24 hours followed by a rebound
was seen (Fig. 8 D, E). This neutrophil depletion resultedin numbers. Antibody binding to neutrophils was not
in complete abrogation of proteinuria and inhibition ofsufficient to induce neutrophil depletion per se, since
glomerular T-cell and monocyte infiltration (Fig. 8).injection of the OX-1 mAb had no effect on blood neu-
In a second experiment, groups of animals were treatedtrophils (Fig. 6 C, D). Transmission electron microscopy
every second day with OX-50 or PHM1 control mAbof blood cell pellets made from OX-50–treated rats iden-
from three hours before anti-GBM serum administrationtified occasional neutrophils in the early stages of apopto-
until being killed on day 10. Treatment with OX-50 mAbsis (Fig. 7).
completely abrogated proteinuria on day 1, consistent
CD44-mediated neutrophil apoptosis in experimental with the results of the first experiment. However, these
renal injury animals subsequently developed moderate to severe pro-
teinuria by days 7 to 10, which was not significantlyCrescentic glomerulonephritis was induced in rats by
immunization with sheep immunoglobulin followed by different to that present in the control mAb-treated
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Fig. 5. Flow cytometry analysis of CD44 ex-
pression by cultured mesangial and tubular
epithelial cells. (A and B) Rat 1097 mesangial
cells and (C and D) NRK52E tubular epithe-
lial cells were cultured and then labeled with
either a negative control antibody 73.5 (A and
C) or with the anti-CD44 antibody OX-50 (B
and D).
Fig. 6. Anti-CD44 monoclonal antibody (mAb)
induces neutrophil apoptosis in vivo. Rats
were killed 20 minutes after a single intrave-
nous injection of 10 mg/kg purified IgG, and
blood cells were analyzed by flow cytometry.
In experiment 1, clear neutrophil (R1) and
lymphocyte (R2) populations were seen on
forward light scatter (FSC) versus 908 side
scatter (SSC) histograms after an injection of
the negative control 73.5 mAb (A); however,
the neutrophil population (R1) was depleted
after injection of the OX-50 mAb (B). In ex-
periment 2, an injection of the OX-1 mAb,
which binds to all leukocytes, had no effect
on the neutrophil (R1) or lymphocyte (R2)
populations (C); however, the administration
of OX-50 mAb again caused a specific deple-
tion of cells from the neutrophil (R1) gate (D).
These data are representative of four separate
experiments.
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Fig. 7. Transmission electron microscopy of OX-50 antibody-induced
neutrophil apoptosis in vivo. Peripheral blood cells were prepared from
a rat 20 minutes after intravenous injection of OX-50 mAb. The poly-
morphonuclear cell (P) is seen undergoing early apoptosis. The nucleus
shows peripheral chromatin condensation, and the cytoplasm appears
dark and condensed. The lymphocyte (L) shows no evidence of apopto-
sis. Magnification 311,000.
group (Fig. 9A). The OX-50 mAb-treated animals also
developed histologic evidence of glomerulonephritis, al-
though these lesions were not as severe as in control
mAb treated animals: glomerular T-cell and monocyte
infiltration (Fig. 9 B, C), glomerular crescent formation
(6.2 6 1.2 vs. 1.6 6 0.8% glomeruli for control vs. OX-50
treated, P , 0.01), and glomerular segmental lesions
(18.5 6 3.1 vs. 9.5 6 1.7% glomeruli for control vs. OX-50
treated, P , 0.01). A 24-hour skin DTH test was per-
formed over days 9 to 10 in the disease model. Skin
swelling was significantly inhibited in the OX-50 mAb-
treated group (Fig. 9D).
c
Fig. 8. Anti-CD44 mAb inhibits the induction of renal injury in rat
glomerulonephritis. Accelerated anti-GBM glomerulonephritis was in-
duced in groups of four animals that were treated with OX-50 (anti-
CD44) or a control antibody before the administration of anti-GBM
serum. Animals were killed on day 1. (A) Twenty-four–hour urinary
protein excretion. (B) W3/131 T-cells per glomerular cross-section
(gcs). (C) ED11 macrophages per gcs. (D) Blood neutrophil numbers
at the time of anti-GBM serum injection. (E) Blood lymphocyte num-
bers at the time of anti-GBM injection. Data are mean 6 SD. *P ,
0.05; **P , 0.01; ***P , 0.001 vs. normal; aP , 0.05; bP , 0.01 vs. OX-50
mAb treated by Tukey’s multiple comparison test (ANOVA).
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Fig. 9. Anti-CD44 mAb fails to inhibit pro-
gression of renal injury in rat glomerulone-
phritis. Accelerated anti-GBM glomerulone-
phritis was induced in groups of six animals
that were treated with OX-50 (anti-CD44) or
a control antibody before administration of
anti-GBM serum and every second day there-
after until being killed on day 10. (A) Twenty-
four–hour urinary protein excretion. (B) W3/
131 T cells per glomerular cross-section (gcs).
(C) ED11 macrophages per gcs. (D) A 24-
hour skin DTH response shown as the change
in skin thickness. Data are mean 6 SD from
groups of six animals. *P , 0.05; **P , 0.01;
***P , 0.001 vs. normal; and aP , 0.05; bP ,
0.01; cP , 0.001 vs. OX-50 treated by t-test (a
and d) or Tukey’s multiple comparison test
(ANOVA; b and c).
DISCUSSION pared with that observed in studies using highly purified
human neutrophils [2]. It is not clear whether this repre-This study has used a combination of in vitro and in
sents an intrinsic difference between rat and human neu-vivo approaches to demonstrate that the OX-50 mAb can
trophils or whether it relates to the methods used ininduce neutrophil apoptosis. The specificity of OX-50–
preparation of these cells. However, the OX-50 mAbinduced neutrophil apoptosis was established in vitro
induced a profound and specific apoptosis of culturedusing four distinct strategies. First, we used the OX-1
rat blood neutrophils in all experiments.mAb to the leukocyte common antigen to demonstrate
Administration of the OX-50 mAb to rats caused athat antibody binding to highly expressed cell-surface
profound neutropenia. Removal of neutrophils from theantigens is not sufficient per se to induce neutrophil
circulation was not due to Fc-mediated effects since in-apoptosis. Second, cross-linking of CD44 was required
jection of the OX-1 mAb, which labels neutrophils atfor the induction of neutrophil apoptosis, as shown by
the same high density as OX-50, had no effect on thesethe lack of effect with F(ab) fragments of the OX-50
cells. We postulate that injection of the OX-50 antibodymAb. This is consistent with the need for cross-linking
leads to very rapid induction of neutrophil apoptoticof the CD44 molecule in the transmission of intracellular
changes, which renders neutrophils susceptible to clear-signals [23, 41]. Third, CD44-mediated neutrophil apo-
ance by mechanisms we have not yet identified. This isptosis was epitope specific, since hyaluronan was unable
supported by the finding of apoptotic neutrophils at 20to induce apoptosis nor was an antibody against the
minutes, which have profound morphological changes.CD44v6 isoform. This is consistent with studies mapping
Given that such changes require time to occur, this dem-the epitope recognized by the OX-50 mAb to a site
onstrates that apoptosis must have been induced verydistinct from the hyaluronan-binding region of the CD44
rapidly after the administration of the OX-50 antibody.molecule [25]. Fourth, CD44-mediated apoptosis was
Inhibition of the 24-hour skin DTH response by OX-50specific to neutrophils because the OX-50 mAb failed
mAb treatment is consistent with previous studies usingto induce apoptosis in other CD44 expressing cell types,
the antineutrophil RP3 mAb, in which mononuclear leu-including lymphocytes, mesangial cells, and tubular epi-
kocyte recruitment and skin swelling in the 24-hour DTHthelial cells. This indicates either a difference in the sig-
response was shown to be neutrophil dependent [38, 39].naling pathways triggered by cross-linking CD44 in neu-
Blood neutrophil depletion by the OX-50 mAb inhibitedtrophils compared with these other cell types, or it may
glomerular injury and glomerular mononuclear cell infil-reflect the unique susceptibility of the neutrophil to un-
tration during the first 24 hours of accelerated anti-GBMdergo apoptosis.
glomerulonephritis. However, OX-50 mAb treatmentIt was interesting that cultured rat blood neutrophils
exhibited a high level of spontaneous apoptosis com- was unable to inhibit the development of glomerulo-
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